Literature DB >> 32704465

MiR-221/222 promote migration and invasion, and inhibit autophagy and apoptosis by modulating ATG10 in aggressive papillary thyroid carcinoma.

Hao Shen1, Zaikai Lin1, Haiyan Shi2, Lingling Wu3, Baojin Ma4, Hong Li5, Baobing Yin4, Jun Tang6, Hongjin Yu7, Xiaoxing Yin1.   

Abstract

MicroRNA (miRNA) has been reported to exert important functions in papillary thyroid carcinomas (PTC). However, the role of miRNA in aggressive PTC (APTC) remains unclear. Here, we investigated the diagnostic potentials and mechanisms of miR-221/222 in APTC. Results showed that miR-221/222 were markedly up-regulated in PTC, compared with the adjacent normal tissue (ANT). A high expression of miR-221/222 were associated with a primary tumor, regional lymph node, and distant metastasis (TNM) stage, multicentricity, lymph node metastasis, and extra-thyroidal extension. Receiver operating characteristic (ROC) curve analysis indicated that miR-221/222 could be used as APTC diagnostic markers. Moreover, miR-221/222 tremendously promoted migration and invasion and inhibited apoptosis and autophagy in PTC cells. A luciferase assay showed that miR-221/222 inhibited the fluorescent activity of autophagy-related protein 10 (ATG10). Furthermore, miR-221/222 decreased ATG10 mRNA and protein levels. Silencing of ATG10 significantly abrogated the effect of miR-221/222 on apoptosis and autophagy. We suggested that miR-221/222 can promote migration and invasion, and inhibit autophagy and apoptosis by targeting ATG10 in APTC. © King Abdulaziz City for Science and Technology 2020.

Entities:  

Keywords:  Aggressive papillary thyroid carcinoma; Diagnostic markers; Receiver operating characteristic curve; microRNA-221/222; qRT-PCR

Year:  2020        PMID: 32704465      PMCID: PMC7363756          DOI: 10.1007/s13205-020-02326-x

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.406


  40 in total

1.  The role of microRNA genes in papillary thyroid carcinoma.

Authors:  Huiling He; Krystian Jazdzewski; Wei Li; Sandya Liyanarachchi; Rebecca Nagy; Stefano Volinia; George A Calin; Chang-Gong Liu; Kaarle Franssila; Saul Suster; Richard T Kloos; Carlo M Croce; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

Review 2.  Thyroid surgery for differentiated thyroid cancer - recent advances and future directions.

Authors:  Tracy S Wang; Julie Ann Sosa
Journal:  Nat Rev Endocrinol       Date:  2018-11       Impact factor: 43.330

3.  miR-221 inhibits autophagy and targets TP53INP1 in colorectal cancer cells.

Authors:  Dan Liao; Tong Li; Caiguo Ye; Liuyan Zeng; Huahui Li; Xingxiang Pu; Congcong Ding; Zhiwei He; Guo-Liang Huang
Journal:  Exp Ther Med       Date:  2017-11-16       Impact factor: 2.447

Review 4.  Thyroid carcinoma.

Authors:  Steven I Sherman
Journal:  Lancet       Date:  2003-02-08       Impact factor: 79.321

Review 5.  Role of autophagy in cancer.

Authors:  Robin Mathew; Vassiliki Karantza-Wadsworth; Eileen White
Journal:  Nat Rev Cancer       Date:  2007-12       Impact factor: 60.716

Review 6.  Autophagy in the pathogenesis of disease.

Authors:  Beth Levine; Guido Kroemer
Journal:  Cell       Date:  2008-01-11       Impact factor: 41.582

7.  Increased expression of ATG10 in colorectal cancer is associated with lymphovascular invasion and lymph node metastasis.

Authors:  Yoon Kyung Jo; Seung Cheol Kim; In Ja Park; So Jung Park; Dong-Hoon Jin; Seung-Woo Hong; Dong-Hyung Cho; Jin Cheon Kim
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

8.  Dual Roles of Two Isoforms of Autophagy-related Gene ATG10 in HCV-Subgenomic replicon Mediated Autophagy Flux and Innate Immunity.

Authors:  Qiong Zhao; Zhan-Ying Hu; Jing-Pu Zhang; Jian-Dong Jiang; Yuan-Yuan Ma; Jian-Rui Li; Zong-Gen Peng; Jin-Hua Chen
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

9.  MiR-221 Exacerbate Cell Proliferation and Invasion by Targeting TIMP3 in Papillary Thyroid Carcinoma.

Authors:  Yingbin Diao; Hongyu Fu; Qian Wang
Journal:  Am J Ther       Date:  2017-05       Impact factor: 2.688

10.  Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model.

Authors:  Brian P Danysh; Erin Y Rieger; Deepankar K Sinha; Caitlin V Evers; Gilbert J Cote; Maria E Cabanillas; Marie-Claude Hofmann
Journal:  Oncotarget       Date:  2016-05-24
View more
  3 in total

1.  Biomarker Value of miR-221 and miR-222 as Potential Substrates in the Differential Diagnosis of Papillary Thyroid Cancer Based on Data Synthesis and Bioinformatics Approach.

Authors:  Shang Cai; Jiayan Ma; Yong Wang; Yuxing Cai; Liwei Xie; Xiangying Chen; Yingying Yang; Qiliang Peng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-07       Impact factor: 5.555

2.  The prognostic value of autophagy related genes with potential protective function in Ewing sarcoma.

Authors:  Jian Wen; Lijia Wan; Xieping Dong
Journal:  BMC Bioinformatics       Date:  2022-07-28       Impact factor: 3.307

3.  Synergistic effects of the combined treatment of U251 and T98G glioma cells with an anti‑tubulin tetrahydrothieno[2,3‑c]pyridine derivative and a peptide nucleic acid targeting miR‑221‑3p.

Authors:  Matteo Zurlo; Romeo Romagnoli; Paola Oliva; Jessica Gasparello; Alessia Finotti; Roberto Gambari
Journal:  Int J Oncol       Date:  2021-07-19       Impact factor: 5.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.